共 12 条
- [1] Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy[J]. NATURE REVIEWS CANCER, 2007, 7 (11) : 880 - 887Colombo, Mario P.Piconese, Silvia
- [2] PD-L1 regulates the development, maintenance, and function of induced regulatory T cells[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (13) : 3015 - 3029Francisco, Loise M.Salinas, Victor H.Brown, Keturah E.Vanguri, Vijay K.Freeman, Gordon J.Kuchroo, Vijay K.Sharpe, Arlene H.
- [3] PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (20) : 9999 - 10008Kamada, TakahiroTogashi, YosukeTay, ChristopherHa, DanbeeSasaki, AkinoriNakamura, YoshiakiSato, EiichiFukuoka, ShotaTada, YasukoTanaka, AtsushiMorikawa, HiromasaKawazoe, AkihitoKinoshita, TakahiroShitara, KoheiSakaguchi, ShimonNishikawa, Hiroyoshi
- [4] Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cells[J]. NATURE IMMUNOLOGY, 2023, 24 (01) : 148 - +Kim, Myeong JoonKim, KyungsooPark, Hyo JinKim, Gil-RanHong, Kyeong HeeOh, Ji HoonSon, JiminPark, Dong JinKim, DahaeChoi, Je-MinLee, InsukHa, Sang-Jun
- [5] Kuchroo JR, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf4034
- [6] Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments[J]. CANCER CELL, 2022, 40 (02) : 201 - +Kumagai, ShogoKoyama, ShoheiItahashi, KotaTanegashima, TokiyoshiLin, Yi-tzuTogashi, YosukeKamada, TakahiroIrie, TakumaOkumura, GenkiKono, HidetoshiIto, DaisukeFujii, RikaWatanabe, ShoSai, AtsuoFukuoka, ShotaSugiyama, EriWatanabe, GoOwari, TakuyaNishinakamura, HitomiSugiyama, DaisukeMaeda, YukaKawazoe, AkihitoYukami, HirokiChida, KeigoOhara, YuukiYoshida, TatsuyaShinno, YukiTakeyasu, YukiShirasawa, MasayukiNakama, KentaAokage, KeijuSuzuki, JunIshii, GenichiroKuwata, TakeshiSakamoto, NaoyaKawazu, MasahitoUeno, ToshihideMori, TaisukeYamazaki, NaoyaTsuboi, MasahiroYatabe, YasushiKinoshita, TakahiroDoi, ToshihikoShitara, KoheiMano, HiroyukiNishikawa, Hiroyoshi
- [7] The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies[J]. NATURE IMMUNOLOGY, 2020, 21 (11) : 1346 - +Kumagai, ShogoTogashi, YosukeKamada, TakahiroSugiyama, EriNishinakamura, HitomiTakeuchi, YoshikoVitaly, KochinItahashi, KotaMaeda, YukaMatsui, ShigeyukiShibahara, TakumaYamashita, YasuhoIrie, TakumaTsuge, AyakaFukuoka, ShotaKawazoe, AkihitoUdagawa, HibikiKirita, KeisukeAokage, KeijuIshii, GenichiroKuwata, TakeshiNakama, KentaKawazu, MasahitoUeno, ToshihideYamazaki, NaoyaGoto, KoichiTsuboi, MasahiroMano, HiroyukiDoi, ToshihikoShitara, KoheiNishikawa, Hiroyoshi
- [8] Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors[J]. CELLULAR IMMUNOLOGY, 2012, 278 (1-2) : 76 - 83Park, Hyo JinKusnadi, AnthonyLee, Eun-JungKim, Won WooCho, Byoung ChulLee, Ik JaeSeong, JinsilHa, Sang-Jun
- [9] PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation[J]. NATURE COMMUNICATIONS, 2015, 6Patsoukis, NikolaosBardhan, KankanaChatterjee, PranamSari, DuyguLiu, BianlingBell, Lauren N.Karoly, Edward D.Freeman, Gordon J.Petkova, VictoriaSeth, PankajLi, LequnBoussiotis, Vassiliki A.
- [10] PD-L1-PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection[J]. NATURE IMMUNOLOGY, 2022, 23 (05) : 743 - +Perry, Joseph A.Shallberg, LindseyClark, Joseph T.Gullicksrud, Jodi A.DeLong, Jonathan H.Douglas, Bonnie B.Hart, Andrew P.Lanzar, ZacharyO'Dea, KeenanKonradt, ChristophPark, JeonghoKuchroo, Juhi R.Grubaugh, DanielZaretsky, Arielle GlatmanBrodsky, Igor E.Malefyt, Rene de WaalChristian, David A.Sharpe, Arlene H.Hunter, Christopher A.